SuPreme Study: a protocol to study the neuroprotective potential of sulfate among very/extremely preterm infants

INTRODUCTION: Antenatal maternal magnesium sulfate (MgSO(4)) administration is a proven efficacious neuroprotective treatment reducing the risk of cerebral palsy (CP) among infants born preterm. Identification of the neuroprotective component with target plasma concentrations could lead to neonatal...

Descripción completa

Detalles Bibliográficos
Autores principales: Hurrion, Elizabeth M, Badawi, Nadia, Boyd, Roslyn N, Morgan, Catherine, Gibbons, Kristen, Hennig, Stefanie, Koorts, Pieter, Chauhan, Manbir, Bowling, Francis, Flenady, Vicki, Kumar, Sailesh, Dawson, Paul A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Paediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10351292/
https://www.ncbi.nlm.nih.gov/pubmed/37451710
http://dx.doi.org/10.1136/bmjopen-2023-076130

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10351292/
https://www.ncbi.nlm.nih.gov/pubmed/37451710
http://dx.doi.org/10.1136/bmjopen-2023-076130

Ejemplares similares